FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis ...Middle East

CRESEMBA is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections Approval based on results of two pediatric studies in children aged 1 to 17 NORTHBROOK, Ill., Dec. 8, 2023 /PRNewswire/ --...

Hence then, the article about fda approves expanded use of cresemba isavuconazonium sulfate in children with invasive aspergillosis and invasive mucormycosis was published today ( Friday 08/12/2023 - 09:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis )

Also on site :

• 1998 ‘Days of Our Lives’ Departure Ended a Record-Breaking Run of Six Distinct Roles That Changed Daytime TV Forever
• Dijo que las Fuerzas Armadas debían estar compuestas por “machos y hembras alfa”. Hoy es el secretario interino de la Marina
• Empresas pagan hasta US$ 4 millones para cruzar el canal de Panamá tras el bloqueo en el estrecho de Ormuz